Tiande Chemical Holdings (SEHK:609) EPS Slide And Thin Margins Test Bullish Valuation Narratives

Tiande Chemical Holdings FY 2025 Earnings Snapshot

Tiande Chemical Holdings (SEHK:609) has laid out a mixed set of FY 2025 numbers, with first half revenue of C¥932.3 million and basic EPS of C¥0.040, alongside trailing twelve month revenue of about C¥1.9 billion and EPS of C¥0.07. Over the last three reported half year periods, revenue has moved between C¥987.8 million in 1H 2024, C¥886.0 million in 2H 2024 and C¥932.3 million in 1H 2025. Basic EPS has ranged from C¥0.0487 to C¥0.028 and then C¥0.040, giving investors a line of sight on how top line and per share earnings have been tracking into the latest release. With trailing net profit margins at 3.3%, a key question is whether the current profitability level sets a stable base or keeps pressure on expectations.

See our full analysis for Tiande Chemical Holdings.

With the headline figures on the table, the next step is to compare these results with the most widely held views on Tiande Chemical Holdings to see which narratives are supported by the numbers and which ones start to look stretched.

Curious how numbers become stories that shape markets? Explore Community Narratives

Five year EPS slide meets mixed recent halves

• Over the past five years, earnings have fallen by an average of 23.2% a year, and within the last three half year periods net income moved from C¥42.4 million in 1H 2024 to C¥24.5 million in 2H 2024 and then C¥35.2 million in 1H 2025. This shows that profitability has been moving around even on top of that longer term decline.
• Bears often focus on that 23.2% annual EPS decline and the step down from C¥66.9 million in trailing net income in 2H 2024 to C¥62.5 million in the latest trailing twelve month figure, arguing that this pattern shows a business still wrestling with pressure on profits.
  • The trailing net profit margin at 3.3%, compared with 3.6% a year earlier, lines up with that cautious view around earnings strength.
  • The move in trailing EPS from C¥0.0766 to C¥0.07 over the same period also fits the bearish argument that per share profitability has been edging down over time.

Curious how others are reading this mix of long term pressure and recent stabilisation in the numbers? Have a look at the broader range of shared views in the community Curious how numbers become stories that shape markets? Explore Community Narratives.

3.3% margin and higher P/E sit side by side

• The latest trailing net margin of 3.3% sits next to a P/E multiple of 17.1x, which is above both the 11.2x peer average and the 9.3x Hong Kong chemicals industry average. The share price at HK$1.38 is therefore being set on richer earnings multiples than many direct comparables even with modest profitability.
• Critics highlight this higher P/E as a key bearish point, arguing that a 3.3% margin and a five year 23.2% annual earnings decline do not obviously justify paying more per unit of earnings than the wider group.
  • The gap to peers, with the stock trading about 6 turns above the 11.2x average, is significant when the margin trend has moved from 3.6% to 3.3% over the last year.
  • That combination of thinner margins and a premium multiple is exactly what bears point to when they question how much room is left if profitability does not show a clearer improvement.

DCF gap versus price and what it really says

• The current share price of HK$1.38 sits roughly 20.4% below the DCF fair value of HK$1.73, so on that specific model the stock screens as below its calculated worth while still showing trailing twelve month EPS of C¥0.07 on C¥1.9b of revenue.
• Supporters often lean on that DCF gap as a bullish talking point, yet the trailing trends in the financials put some useful guardrails around that optimism.
  • The DCF gap exists alongside trailing net income slipping from C¥66.9 million to C¥62.5 million across the last two trailing snapshots, which keeps the focus on how durable any valuation case really is.
  • Even with that implied 20.4% upside to DCF fair value, the elevated 17.1x P/E compared with the 9.3x industry average shows that any bullish stance rests on paying a higher multiple today while earnings have a recent history of decline.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Tiande Chemical Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Mixed signals in the earnings and valuation story so far? Take a closer look at the numbers yourself and weigh both sides of the debate using 1 key reward and 1 important warning sign.

See What Else Is Out There

Tiande Chemical Holdings is working with a 3.3% net margin, a 17.1x P/E, and a five year 23.2% annual EPS decline, which raises questions about paying a premium multiple.

If that mix of thin margins and premium pricing feels uncomfortable, you can compare it with companies that pair stronger fundamentals and balance sheets by checking the solid balance sheet and fundamentals stocks screener (382 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com